Further studies of the butyrophenone, CI-601, in chronic schizophrenic patients.
D000328:Adult; D002090:Butyrophenones / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy*
D002090:Butyrophenones; D010919:Placebos; D006220:Haloperidol